D. Galdermans
- Pulmonary and Respiratory Medicine top 5%
- Oncology top 10%
- Public Health, Environmental and Occupational Health
- Molecular Biology
- Geriatrics and Gerontology top 5%
- Co-authors
- Denis SchallierJacques De GrèveErik TeugelsLore DecosterCaroline GeersPieter In 'T VeldJohan De MeyHendrik Everaert
- Topics
- Lung Cancer Treatments and Mutations (12 papers)Palliative Care and End-of-Life Issues (6 papers)Lung Cancer Research Studies (6 papers)
- Journals
- Journal of Clinical OncologyAmerican Journal of Respiratory and Critical Care MedicineCHEST Journal
- Partner nations
- BelgiumNetherlandsUnited States
In The Last Decade
D. Galdermans
35 papers receiving 762 citations
Peers
Comparison fields: 5 of 72
- Pulmonary and Respiratory Medicine 444
- Oncology 374
- Public Health, Environmental and Occupational Health 138
- Molecular Biology 128
- Geriatrics and Gerontology 103
Countries citing papers authored by D. Galdermans
This map shows the geographic impact of D. Galdermans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Galdermans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Galdermans more than expected).
Fields of papers citing papers by D. Galdermans
This network shows the impact of papers produced by D. Galdermans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Galdermans. The network helps show where D. Galdermans may publish in the future.
Co-authorship network of co-authors of D. Galdermans
This figure shows the co-authorship network connecting the top 25 collaborators of D. Galdermans. A scholar is included among the top collaborators of D. Galdermans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Galdermans. D. Galdermans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 21 | |
| 3 | 25 | |
| 4 | 69 | |
| 5 | 21 | |
| 6 | 7 | |
| 7 | 9 | |
| 8 | 215 | |
| 9 | First-line erlotinib in advanced non-small cell lung cancer (NSCLC) carrying an activating EGFR mutation: A multicentre academic phase II study in caucasian patients (pts) (NCT00339586) | 1 |
| 10 | 42 | |
| 11 | Clinical activity of BIBW 2992, an irreversible inhibitor of EGFR and HER2 in adenocarcinoma of the lung with mutations in the kinase domain of HER2neu | 20 |
| 12 | 6 | |
| 13 | 12 | |
| 14 | 22 | |
| 15 | 8 | |
| 16 | 2 | |
| 17 | 3 | |
| 18 | 18 | |
| 19 | 11 | |
| 20 | 2 |
About D. Galdermans
D. Galdermans is a scholar working on Microbiology, Geriatrics and Gerontology and Pulmonary and Respiratory Medicine, having authored 35 papers that have together received 781 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (12 papers), Palliative Care and End-of-Life Issues (6 papers) and Lung Cancer Research Studies (6 papers). The work is most often cited by research in Geriatrics and Gerontology (103 citations), Oncology (374 citations) and Pulmonary and Respiratory Medicine (444 citations). D. Galdermans has collaborated with scholars based in Belgium, Netherlands and United States. Frequent co-authors include Denis Schallier, Jacques De Grève, Erik Teugels, Lore Decoster, Caroline Geers, Pieter In 'T Veld, Johan De Mey, Hendrik Everaert, Ijeoma Adaku Umelo and Jeroen Mebis. Their work appears in journals such as Journal of Clinical Oncology, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.